Acute megakaryocytic leukemia

Maureen McNulty, John D. Crispino*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Acute megakaryoblastic leukemia (AMKL) is a rare malignancy affecting megakaryocytes, platelet-producing cells that reside in the bone marrow. Children with Down syndrome (DS) are particularly prone to developing the disease and have a different age of onset, distinct genetic mutations, and better prognosis as compared with individuals without DS who develop the disease. Here, we discuss the contributions of chromosome 21 genes and other genetic mutations to AMKL, the clinical features of the disease, and the differing features of DS-and non-DS-AMKL. Further studies elucidating the role of chromosome 21 genes in this disease may aid our understanding of how they function in other types of leukemia, in which they are frequently mutated or differentially expressed. Although researchers have made many insights into understanding AMKL, much more remains to be learned about its underlying molecular mechanisms.

Original languageEnglish (US)
Article numbera034884
JournalCold Spring Harbor Perspectives in Medicine
Volume10
Issue number2
DOIs
StatePublished - Feb 2020

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Acute megakaryocytic leukemia'. Together they form a unique fingerprint.

  • Cite this